Riskpilot← Back to searchSign inGet full accessINNOSURGE AS
ASActiveOrg 812806572Hennumbråtan 15, 3409 TranbyWholesale of pharmaceutical and medical goods · NACE 4646Est. 20130 employeeswww.maerskandersen.com
Revenue 2020
NOK 0
EBITDA margin
—
-100% vs 2019
Equity ratio
2.9%
Financial strength
Net profit 2020
NOK 971K
-97% vs 2019
| Revenue | NOK 0 | — |
| EBITDA | NOK -68K | -100% |
| Net profit | NOK 971K | -97% |
| Total assets | NOK 5,5M | -84% |
| Equity | NOK 160K | +79% |
| Employees | 0 | — |
Legal name
INNOSURGE AS
Org number
812806572
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19. desember 2013
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Salg av medisinsk utstyr og utstyr til helsesektoren generelt og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Hennumbråtan 15, 3409 Tranby
Website
www.maerskandersen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 20 266 | 26 399 | 33 114 | 60 736 | 0 |
| Staff expenses | −1 617 | −2 124 | −2 164 | −1 806 | 57 |
| EBITDA | 4 560 | 6 941 | 9 434 | 36 642 | −68 |
| Depreciation & amort. | −22 | −0 | −570 | −161 | −0 |
| EBIT | 4 537 | 6 941 | 8 863 | 36 481 | −68 |
| Net financials | 6 | −79 | −47 | 55 | 1 307 |
| Profit before tax | 4 543 | 6 862 | 8 816 | 36 536 | 1 239 |
| Tax | 1 097 | 1 653 | 2 083 | 8 088 | 269 |
| Net profit | 3 447 | 5 210 | 6 734 | 28 448 | 971 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 7 283 | 9 008 | 11 334 | 34 942 | 5 480 |
| Equity | 94 | 53 | 37 | 90 | 160 |
| Long-term debt | 4 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 186 | 8 955 | 11 297 | 34 852 | 5 320 |
| Total debt | 7 190 | 8 955 | 11 297 | 34 852 | 5 320 |
EBITDA margin
-6815300.0%
This company
15.8%
Market median
-43134910% vs market
20162020
Equity ratio
2.9%
This company
38.2%
Market median
-92% vs market
20162020
Return on equity
605.1%
This company
18.4%
Market median
+3189% vs market
20162020
Net profit margin
97054000.0%
This company
8.1%
Market median
+1198197431% vs market
20162020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162020
Debt / equity
33.17×
This company
0.62×
Market median
-5250% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2016 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INNOSURGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Maigaard Nielsen | Deputy Member | 0 companies |
| Heinz Kvottrup Lorentzen | Board of Directors | 0 companies |
| Bjørn Flåtrud | Chairman | 0 companies |
| Henrik Forsberg | Board of Directors | 0 companies |